Table 3 |
||||||||||||||||
|
ORs ofHPV positivity and corresponding 95% CIs according to selected characteristics among 138 HIV-positive womena. Santos, São Paulo, Brazil, 1996–1997 |
||||||||||||||||
|
Cervical+Vaginal |
Cervical+Analb |
Vaginal+Analb |
Cervical+Vaginal+Analb |
|||||||||||||
|
|
||||||||||||||||
|
Tot. No |
Pos. (%) |
ORc |
95% CI |
Tot. No |
Pos. (%) |
ORc |
95% CI |
Tot. No |
Pos. (%) |
ORc |
95% CI |
Tot. No |
Pos. (%) |
ORc |
95% CI |
|
|
|
||||||||||||||||
|
Age (years) |
||||||||||||||||
|
≥ 35 |
39 |
38.5 |
1 |
30 |
10.0 |
1 |
30 |
13.3 |
1 |
30 |
6.7 |
1 |
||||
|
25–34 |
75 |
49.3 |
1.6 |
0.7–3.4 |
55 |
27.3 |
3.4 |
0.9–12.8 |
55 |
34.6 |
3.4 |
1.0–11.3 |
55 |
27.3 |
5.3 |
1.1–24.8 |
|
< 25 |
24 |
58.3 |
2.2 |
0.8–6.3 |
17 |
47.1 |
8.0 |
1.7–36.8 |
17 |
41.2 |
4.6 |
1.1–19.0 |
17 |
35.3 |
7.6 |
1.3–43.8 |
|
p for trend |
0.12 |
0.006 |
0.03 |
0.02 |
||||||||||||
|
Tobacco smoking |
||||||||||||||||
|
Never smoker |
44 |
45.5 |
1 |
32 |
31.3 |
1 |
32 |
31.3 |
1 |
32 |
21.9 |
1 |
||||
|
Ex-smoker |
33 |
45.5 |
1.1 |
0.4–2.8 |
26 |
30.8 |
1.1 |
0.3–3.8 |
26 |
34.6 |
1.2 |
0.4–3.7 |
26 |
30.8 |
1.7 |
0.5–6.1 |
|
Current smoker |
61 |
50.8 |
1.3 |
0.6–3.0 |
44 |
18.2 |
0.5 |
0.2–1.7 |
44 |
25.0 |
0.8 |
0.3–2.2 |
44 |
18.2 |
0.9 |
0.3–2.9 |
|
p for trend |
0.46 |
0.22 |
0.52 |
0.60 |
||||||||||||
|
Drug addict |
||||||||||||||||
|
Never |
79 |
45.6 |
1 |
62 |
25.8 |
1 |
62 |
25.8 |
1 |
62 |
21.0 |
1 |
||||
|
Ex |
36 |
52.8 |
1.3 |
0.6–2.8 |
24 |
29.2 |
1.1 |
0.4–3.2 |
24 |
45.8 |
2.2 |
0.8–6.2 |
24 |
29.2 |
1.4 |
0.5–4.2 |
|
Current |
23 |
47.8 |
1.0 |
0.4–2.7 |
16 |
18.8 |
0.7 |
0.2–2.9 |
16 |
18.8 |
0.6 |
0.2–2.6 |
16 |
18.8 |
0.8 |
0.2–3.5 |
|
p for trend |
0.80 |
0.70 |
0.99 |
0.98 |
||||||||||||
|
Years since HIV diagnosis |
||||||||||||||||
|
≤ 1 |
54 |
46.3 |
1 |
40 |
27.5 |
1 |
40 |
32.5 |
1 |
40 |
22.5 |
1 |
||||
|
2–4 |
43 |
39.5 |
0.8 |
0.4–1.9 |
34 |
60.529.4 |
1.3 |
0.4–3.8 |
34 |
32.4 |
1.0 |
0.4–2.8 |
34 |
26.5 |
1.3 |
0.4–4.2 |
|
≥ 5 |
39 |
56.4 |
1.8 |
0.7–4.2 |
26 |
19.2 |
0.7 |
0.2–2.8 |
26 |
23.1 |
0.5 |
0.2–1.9 |
26 |
19.2 |
0.8 |
0.2–3.1 |
|
p for trend |
0.25 |
0.73 |
0.38 |
0.81 |
||||||||||||
|
CD4 count/mm3 |
||||||||||||||||
|
≥ 500 |
34 |
41.2 |
1 |
20 |
15.0 |
1 |
20 |
15.0 |
1 |
20 |
10.0 |
1 |
||||
|
200–499 |
51 |
49.0 |
1.8 |
0.7–4.7 |
39 |
23.1 |
4.2 |
0.8–22.2 |
39 |
30.8 |
4.8 |
1.0–22.7 |
39 |
23.1 |
5.7 |
0.9–34.1 |
|
< 200 |
53 |
59.9 |
1.8 |
0.7–4.6 |
43 |
32.6 |
5.9 |
1.2–28.6 |
43 |
34.9 |
5.0 |
1.1–22.4 |
43 |
27.9 |
6.2 |
1.1–34.9 |
|
p for trend |
0.24 |
0.03 |
0.06 |
0.06 |
||||||||||||
|
Commercial sex worker |
||||||||||||||||
|
Never |
107 |
46.7 |
1 |
82 |
24.4 |
1 |
82 |
26.8 |
1 |
82 |
20.7 |
1 |
||||
|
Ever |
31 |
51.6 |
1.2 |
0.5–2.6 |
20 |
30.0 |
1.2 |
0.4–3.8 |
20 |
40.0 |
1.7 |
0.6–4.8 |
20 |
30.0 |
1.5 |
0.5–4.6 |
|
Lifetime number of sexual partners |
||||||||||||||||
|
≤ 2 |
34 |
41.2 |
1 |
26 |
26.9 |
1 |
26 |
30.8 |
1 |
26 |
26.9 |
1 |
||||
|
3–5 |
44 |
52.3 |
1.5 |
0.6–3.8 |
35 |
25.7 |
0.9 |
0.3–2.9 |
35 |
25.7 |
0.7 |
0.2–2.3 |
35 |
17.1 |
0.5 |
0.1–1.8 |
|
≥ 6 |
60 |
48.3 |
1.2 |
0.5–3.0 |
41 |
24.4 |
0.7 |
0.2–2.3 |
41 |
31.7 |
0.8 |
0.3–2.6 |
41 |
24.4 |
0.7 |
0.2–2.2 |
|
p for trend |
0.63 |
0.32 |
0.85 |
0.53 |
||||||||||||
|
Recent sexual partnersd |
||||||||||||||||
|
0 |
48 |
43.8 |
1 |
42 |
21.4 |
1 |
42 |
26.2 |
1 |
42 |
21.4 |
1 |
||||
|
1 |
74 |
47.3 |
1.0 |
0.5–2.1 |
51 |
25.5 |
0.8 |
0.3–2.4 |
51 |
27.5 |
0.8 |
0.3–2.0 |
51 |
19.6 |
0.6 |
0.2–1.7 |
|
≥ 2 |
13 |
76.9 |
3.5 |
0.8–15.0 |
9 |
44.4 |
2.2 |
0.5–10.7 |
9 |
55.6 |
2.6 |
0.5–12.0 |
9 |
44.4 |
2.0 |
0.4–9.5 |
|
p for trend |
0.21 |
0.56 |
0.52 |
0.83 |
||||||||||||
|
Condom used |
||||||||||||||||
|
Yes |
69 |
47.8 |
1 |
47 |
25.5 |
1 |
47 |
27.7 |
1 |
47 |
19.2 |
1 |
||||
|
No |
20 |
60.0 |
1.7 |
0.6–4.8 |
13 |
38.5 |
2.0 |
0.5–7.6 |
13 |
46.2 |
2.4 |
0.7–8.8 |
13 |
38.5 |
2.9 |
0.7–11.6 |
|
Anal intercourse |
||||||||||||||||
|
Never |
66 |
48.5 |
1 |
51 |
19.6 |
1 |
51 |
19.6 |
1 |
51 |
19.6 |
1 |
||||
|
Ever |
72 |
47.2 |
0.9 |
0.5–1.8 |
51 |
31.4 |
1.7 |
0.6–4.3 |
51 |
39.2 |
2.4 |
0.97–6.0 |
51 |
25.5 |
1.2 |
0.5–3.2 |
|
|
||||||||||||||||
|
aSome figures do not add up to the total due to missing values; bPresented for 102 HIV-positive women; cAdjusted for age. HPV = human papillomavirus; d relative to the last 6 months preceding interview; HIV = human immunodeficiency virus; OR = odds ratio; CI = confidence intervals. |
||||||||||||||||
|
Gonçalves et al. Infectious Agents and Cancer 2008 3:5 doi:10.1186/1750-9378-3-5 |
||||||||||||||||